TMS Therapy Success Rate – Latest Studies Backed Results

What is TMS Therapy?

Transcranial Magnetic Stimulation is a non-invasive treatment that uses magnetic fields to stimulate nerve cells in the brain. This FDA-approved treatment primarily targets areas of the brain involved in mood regulation. It is most often used for major depressive disorder (MDD), especially in patients who are non-responsive to traditional therapy and medication approaches.

According to the National Institute of Mental Health, more than 21 million adults in the U.S suffer from major depressive disorder (MDD) each year, with many unable to find relief through conventional methods. This is where TMS therapy excels as a state-of-the-art option. As a safe, drug-free alternative with minimal side effects, this therapy is rapidly growing in popularity and use across the country.

In addition to being used to treat MDD, TMS therapy is used for the following conditions:

• Anxiety disorders
• PTSD and CPTSD
• OCD

Mechanically, TMS works by placing a magnetic coil on the scalp and delivering pulses that modulate the brain’s natural electrical activity. Patients remain awake and alert during treatment sessions. This is why you’ll often hear the treatment referred to as rTMS (repetitive TMS), because treatment involves repeated pulses over multiple sessions.

Understanding the success rate of TMS therapy is critical in helping families and patients set their expectations. With the right information, you can make an informed decision about your care. In this guide, we’ll cover everything you need to know about TMS’s success rate, the latest studies about this exciting treatment option, and how you can work with your care team to incorporate TMS into your treatment.

Why Success Rates Are Important

One of the first questions patients ask when considering TMS is “Will it work for me?” Success rates give data that help ease this uncertainty and help patients set realistic expectations. Additionally, success rates are not just numbers and data – they help guide clinicians in recommending TMS in situations where studies show it could provide positive outcomes.

In order to understand these studies and their reported success rates, let’s break down two concepts: response vs. remission. A response rate refers to a significant improvement in symptoms, often defined as 50% or greater reduction in depression symptoms or severity. Remission rate refers to a complete or near-complete relief of symptoms.

While each individual’s experience with TMS will differ, reviewing a broad range of scientific data can help determine which TMS protocol may help with a patient’s case of depression or other mood disorders. Different types of TMS treatment work in different ways and on different schedules, and the data behind these differences can help you and your provider find the right option for your needs.

Beyond helping set expectations and guidelines for when TMS is appropriate to recommend, success rates help clinicians and patients compare TMS with other treatment options. Success rates not only provide an immediate view of a treatment’s effectiveness but also a view of long-term outcomes.

Latest Studies & Backed Results

One of the most promising recent studies on TMS therapy was done by UCLA Health. This study found that more than half of patients responded positively to repetitive TMS (rTMS). This study analyzed hundreds of patients who received TMS treatment at UCLA Health from 2009 to 2022.

UCLA Health takes a unique approach to its rTMS therapy, allowing it to track data and success outcomes at the minute level. Patients see a psychiatrist at every therapy appointment and complete a symptom rating scale weekly. This provides clinicians with a large dataset they can use to measure both short- and long-term outcomes.

According to the Vida et al. (2023) BMC Psychiatry meta‑analysis, patients treated with rTMS were nearly three times more likely to achieve remission, with a remission rate of 35% percent compared to the control group’s 8%. In this study, those with specifically treatment-resistant depression were tested.

Beyond success rate studies, research is also being conducted on the worldwide recognition and adoption of TMS. This 2025 study analyzed over 600 published research papers from 1996 to 2023 and found that TMS is increasingly recognized worldwide as a safe, effective treatment. It also found that research into TMS is expanding, with different researchers and organizations looking into its effectiveness for treating depression, schizophrenia, and neurorehabilitation. These studies show that the future of TMS is bright and ever-expanding.

Factors That Influence Success

Overall, it’s important to remember that success rates vary depending on a patient’s primary diagnosis. While meta-analyses show response rates of up to 50%-60% for treatment-resistant depression, the rates are lower at 25%-30% for late-life depression. Treatment history is also a significant factor in the success of treatment. Those who have failed two or more antidepressant trials are considered treatment-resistant, and rTMS is noted in studies above to be effective at treating this type of depression.

Another major factor in success rates is the specific type of TMS therapy used. Standard rTMS involves daily sessions lasting 4 to 6 weeks. Deep TMS is an emerging therapy that targets deeper brain structures and may require greater commitment. There are even protocols for multiple sessions per day. The choice of therapy protocol significantly influences outcomes, patient commitment, and required resources.

Tied to the chosen protocol’s intensity and schedule, consistency and adherence are also factors that influence success. Missing treatments in any protocol will reduce treatment efficacy. Studies across the board show that patients who complete a full course of treatment are twice as likely to achieve remission as those with irregular attendance.

Why Choose BNI Clinics

Transcranial magnetic stimulation (TMS) is a safe, effective, and evidence-based treatment for major depressive disorder and other mood conditions. Clinical analyses consistently show that response rates of 50% to 65% are standard, with remission rates of 30% to 40% common as well. Beyond the individual outcomes, researchers across the world are looking into ways that TMS can actively help patients worldwide with expanding studies into depression, anxiety, and PTSD. For those who have struggled with traditional treatment and medications, TMS offers a renewed hope that is backed by science.

With BNI Clinics, you can rest assured in the fact that we align our treatment protocols with the latest research. We work hard to ensure patients receive the most advanced evidence-based care available. Our team of experienced providers is here to tailor a TMS therapy plan to your needs, designed to maximize impact and support your long-term recovery. If you or a loved one is exploring this alternative to medication for depression and other mood disorders, reach out to BNI Clinics today to schedule a consultation.